October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
|Articles|February 8, 2022
Daily OTC Pearl: PainBloc
Author(s)Saro Arakelians, PharmD
PainBloc inhibits joint pain from arthritis at the source.
Advertisement
OTC/Lifestyle Pearl of the Day: PainBloc
Indication: Relieving arthritis pain, bruises, and sprains.
Insight:
- PainBloc is an OTC topical product that inhibits joint pain at the source and deactivates certain receptors.
- Active ingredients: Capsaicin 0.25% topical analgesic.
- Do not apply to wounds.
- When applying, a temporary burn pain may occur, which is normal.
- When applied, wait 30 minutes before washing it off.
- Apply to the affected area until visibly moist.
- Inactive ingredients include alcohol, diethylene glycol, monoethyl ether, hyaluronate sodium, polysorbate 80, propylene glycol, and water.
- Manufacturer: Vizuri Health Sciences
Sources:
Advertisement
Related to this article
Cody Parsons, APh, PharmD, BCCCP, says protected pharmacist access lets patients with heart failure be seen more often than typical clinic visits allow.
The evidence for GLP-1 receptor agonists keeps growing, while access for low-income patients keeps narrowing.
Specialty pharmacists can help patients with cancer weigh the benefits and risks of GLP-1 receptor agonists as use expands and new evidence emerges.
Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
GLP-1 Receptor Agonists and Cancer: Considerations for Specialty Pharmacists
3
GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers
4
Amivantamab Becomes First FDA-Approved Therapy in 10 Years for Pretreated Recurrent or Metastatic HNSCC
5